Evidence map›Paper›PMID 42387501›Full record

ReviewCancer cell international2026

The pro-metastatic role of microbiota in tumors: a comprehensive review.

Xiaokun Chen, Xiao Liu, Jie Gong, Shunda Du

Abstract readReview
In one paragraph

Review in Cancer cell international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaokun ChenDepartment of Liver Surgery, State Key Laboratory of Common Mechanism Research for Major Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
Xiao LiuDepartment of Liver Surgery, State Key Laboratory of Common Mechanism Research for Major Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
Jie GongNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. gongjie@icdc.cn.
Shunda DuDepartment of Liver Surgery, State Key Laboratory of Common Mechanism Research for Major Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China. dushd@pumch.cn.

Funding

Changzhou Xi Tai Hu development foundation for frontier cell-therapeutic technology 2024-P-019National Natural Science Foundation of China 819726982the 2021 Liver Cancer Diagnosis and Treatment Exchange Fund of Hubei Chen Xiaoping Science and Technology Development Foundation CXPJJH1200009-01the CAMS Innovation Fund for Medical Sciences CIFMS 2021-I2M-01-014the Central High-level Hospital Clinical Research Special Key Cultivation Project 2022-PUMCH-C-047
6 · The paper itself

Abstract

Cancer metastasis remains a major obstacle in oncology and significantly worsens patient outcomes. A key challenge lies in understanding when and how tumor cells overcome biological barriers to spread, and to what extent external or internal factors modulate this process. Among these, the human microbiota-comprising trillions of microbes vastly outnumbering human cells-has emerged as a crucial regulator of both health and disease. Recent studies have identified the presence of microbiotas within tumor tissues; these microbes, together with other stromal elements, shape the tumor microenvironment (TME) and critically influence cancer progression and metastasis. Notably, intratumor microbiotas have been implicated in altering local immune responses, inducing DNA damage, and reprogramming cancer-associated pathways. These groundbreaking findings have expanded our understanding of tumor biology and offer promising therapeutic avenues. In this review, we aim to comprehensively summarize current evidence on how intratumor microbes contribute to tumor progression and metastasis. We further highlight how modulation of these microbes may serve as a novel anticancer strategy. We also discuss gaps in the literature and propose future research directions that can bridge the bench-to-bedside translation.

Indexed as

Cancer metastasisIntratumor microbiotaMicrobiotaTumor microenvironment

Identifiers

PMID42387501
PMCPMC13595524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.